Arkolith/Insider Trading/EDSA/Form 4

Nijhawan Pardeep

Chief Executive Officer, Director, 10% OwnerEdesa Biotech, Inc. (EDSA) · full profile →Form 4 · filed Jun 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2025Grant(A)8K—$0450K
May 29, 2025Grant(A)263K—$0442K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-25-003590) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML